Nephron Pharmaceuticals Corp. and Rapid Micro Biosystems announced the Nephron 503(b) Outsourcing division will deliver critical medical supplies to hospitals using a new tool that automates microbial monitoring in the drug manufacturing process.   As the first and only growth-based system of its kind in microbial testing, Growth Direct™ automates the incubation, colony counting, and data entry of microbial environmental testing. Growth Direct, now in use at Nephron, also detects any potential...